REVIEW OF LONG-TERM TRIALS WITH NITRENDIPINE

被引：6

作者：

HULTHEN, UL ^{[1
]}

KATZMAN, PL ^{[1
]}

机构：

[1] LUND UNIV CLIN, MALMO GEN HOSP, DEPT ENDOCRINOL, S-21401 MALMO, SWEDEN

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1988年 / 12卷

关键词：

D O I：

10.1097/00005344-198806124-00004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S11 / S15

页数：5

共 43 条

[1]

BOLLI P, 1984, J CARDIOVASC PHARM, V6, pS996

[2]

BURRIS JF, 1987, J CARDIOVASC PHAR S4, V9, pS306

[3]

CORSING C, 1987, J CARDIOVASC PHAR S4, V9, pS136

[4]

DEDIVITIIS O, 1985, ARZNEIMITTEL-FORSCH, V35-1, P727

[5] EFFECT OF THE CALCIUM-CHANNEL BLOCKER NITRENDIPINE ON LEFT-VENTRICULAR MASS IN PATIENTS WITH HYPERTENSION [J].

DRAYER, JIM ;

HALL, WD ;

SMITH, VE ;

WEBER, MA ;

WOLLAM, GL ;

WHITE, WB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (06) :679-685

[6]

DUSTAN HP, 1987, J CARDIOVASC PHAR S4, V9, pS267

[7]

ESPER RJ, 1987, J CARDIOVASC PHAR S4, V9, pS164

[8] ANTIHYPERTENSIVE AND CARDIOVASCULAR EFFECTS OF NITRENDIPINE - A CONTROLLED-STUDY VS PLACEBO [J].

FERRARA, LA ;

FASANO, ML ;

DESIMONE, G ;

SORO, S ;

GAGLIARDI, R .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :434-438

[9]

FRANCISCHETTI EA, 1987, J CARDIOVASC PHAR S4, V9, pS107

[10]

FRITSCHKA E, 1984, J CARDIOVASC PHARM, V6, P1100

← 1 2 3 4 5 →